All news

Researchers say low doses of fish oil resulted in a seizure frequency 33.6% lower than the placebo control.

Omega-3 may reduce epilepsy seizures

By Annie Harrison-Dunn

Low doses of omega-3 rich fish oil may reduce epilepsy seizure frequency by around a third, according to research published in the British Medical Journal.

Science grows for BLIS M18’s oral health benefits

Science grows for BLIS M18’s oral health benefits

By Stephen DANIELLS

A daily lozenge containing Streptococcus salivarius M18, branded as BLIS M18, for 28 days results in detectable levels of the probiotic in the mouth seven days later, says a new study from Western University (Ontario) and BLIS Technologies Ltd (New Zealand).

International association endorses Botanical Adulterants Program

International association endorses Botanical Adulterants Program

By Hank Schultz

A major self policing and informational effort in the dietary supplement industry has received a signifcant boost on the international stage.  The Botanical Adulterants program, a coopertive venture of three North American-based organizaitons, has been...

Euromonitor, Naturex on vitamins and supplement growth in Mexico

Special edition: LATAM

Obesity prevention key to Mexican vitamin & supplement market growth

By Maggie Hennessy

Sales of vitamins and dietary supplements grew 9% in 2013 to reach Mx$15.7 billion ($1.2 billion) as increased visibility over the country’s main diseases have consumers thinking more about prevention, according to a report from Euromonitor International. 

Jeff Bland and Elwood Richard among annual NPA award honorees

Jeff Bland and Elwood Richard among annual NPA award honorees

By Stephen DANIELLS

Elwood Richard, the founder and former president of NOW Foods, and Jeffrey Bland, PhD, a leader in nutritional medicine, are just two of the ‘top-tier professionals in the natural products industry’ to be honored by the Natural Products Association at...

“Work on further reducing production costs will continue post-launch...

Swiss player ready for reduced cost resveratrol launch

By Shane STARLING

10-year-old Swiss biotech firm Evolva has completed the resveratrol manufacturing cost-reduction programme it embarked on for the antioxidant nearly two years ago when it bought defunct Fluxome’s business for €550,000.

Arla will triple whey hydrolysates output by 2016

Arla pours €38m into facility to meet whey demand

By Shane STARLING

Dairy giant Arla's ingredients business is building a new whey processing facility for €38m to meet rising demand for the dairy fraction in infant, sports and clinical nutrition.

Follow us

Products

View more

Webinars